Researchers are excited about the medication , a innovative dual agonist showing promising results in clinical trials for size loss . It acts by modulating both systems: GLP-1 and GIP, that , when https://rafaeltepb735406.wssblogs.com/40680128/this-new-hope-for-body-reduction